Immune checkpoint inhibitor rechallenge in patients with immune-related myositis.

Autor: Delyon J; Department of Dermatology, APHP Saint Louis Hospital, Paris, France julie.delyon@aphp.fr.; INSERM U976, Paris, France.; Paris Diderot, Sorbonne Paris Cité University, Paris, France., Brunet-Possenti F; Paris Diderot, Sorbonne Paris Cité University, Paris, France.; Department of Dermatology, APHP Bichat Hospital; Paris VII Diderot, Sorbonne Paris Cité University, Paris, France., Leonard-Louis S; Department of Neurology and Neuropathology, APHP Pitié-Salpêtrière Hospital, Paris, France.; UPMC, Médecine Sorbonne Université, Paris, France., Arangalage D; Paris Diderot, Sorbonne Paris Cité University, Paris, France.; Cardiology Department, APHP Bichat Hospital, Paris, France.; INSERM U1148, Paris, France., Baudet M; Department of Cardiology, APHP Saint Louis Hospital, Paris, France., Baroudjian B; Department of Dermatology, APHP Saint Louis Hospital, Paris, France., Lebbe C; Department of Dermatology, APHP Saint Louis Hospital, Paris, France.; INSERM U976, Paris, France.; Paris Diderot, Sorbonne Paris Cité University, Paris, France., Hervier B; UPMC, Médecine Sorbonne Université, Paris, France.; Department of Internal Medicine, APHP Pitié-Salpêtrière Hospital, Paris, France.; INSERM U1135-CIMI, Paris, France.
Jazyk: angličtina
Zdroj: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Nov; Vol. 78 (11), pp. e129. Date of Electronic Publication: 2018 Sep 21.
DOI: 10.1136/annrheumdis-2018-214336
Abstrakt: Competing Interests: Competing interests: BH, DA, JD, FBP, MB and SLL had nothing to declare. BB received payments for lectures/boards and travel accommodations from BMS and MSD. CL received research grants or honoraria from Roche, BMS, MSD, GSK, Novartis and Amgen.
Databáze: MEDLINE